HNF1B mutation in a Turkish child with renal and exocrine pancreas insufficiency, diabetes and liver disease

Pediatric Diabetes

Volumn 13, Issue 2, 2012, Pages

  Gonc, E Nazli ^a   Ozturk, Burcu Bulum ^a   Haldorsen, Ingfrid S ^b   Molnes, Janne ^c   Immervoll, Heike ^b,c   Ræder, Helge ^c   Molven, Anders ^b,c   Søvik, Oddmund ^c   Njølstad, Pål R ^b,c  

^a HACETTEPE UNIVERSITY   (Turkey)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Diabetes mellitus, type 2; Gene; Hepatocyte nuclear factor 1 beta; Kidney failure, chronic; Pancreas, exocrine

Indexed keywords

ANTACID AGENT; BICARBONATE; CALCITRIOL; CALCIUM ACETATE; ENALAPRIL; ESSENTIAL AMINO ACID; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 1BETA; INSULIN; IRON; ISOPHANE INSULIN;

ANEMIA; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; EXON; FATTY LIVER; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLUCOSURIA; HEMATOPOIESIS; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPERTENSION; INFANT; KIDNEY HYPOPLASIA; LEUKOCYTOSIS; LIVER BIOPSY; LIVER DYSFUNCTION; METABOLIC ACIDOSIS; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS MALFORMATION; PHENOTYPE; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; SMALL FOR DATE INFANT; TURKEY (BIRD);

BASE SEQUENCE; DIABETES MELLITUS, TYPE 1; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN; LIVER DISEASES; MOLECULAR SEQUENCE DATA; MUTATION; RENAL INSUFFICIENCY; SEVERITY OF ILLNESS INDEX; TURKEY;

EID: 84857504562     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2011.00773.x     Document Type: Article

References (22)

1. Horikawa Y, Iwasaki N, Hara M et al. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet 1997: 17: 384-385.
2. Søvik O, Sagen JV, Njølstad PR. TCF2 (HNF-1β) and MODY5 and Urogenital Malformations. In: Epstein CJ, Erickson RP, Wynshaw-Boris A eds. Inborn Errors of Development. 2nd edn. New York: Oxford University Press, 2008.
3. Bingham C, Hattersley AT. Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1beta. Nephrol Dial Transplant 2004: 19: 2703-2708.
4. Bellanne-Chantelot C, Chauveau D, Gautier JF et al. Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med 2004: 140: 510-517.
5. Haldorsen IS, Vesterhus M, Raeder H et al. Lack of pancreatic body and tail in HNF1B mutation carriers. Diabet Med 2008: 25: 782-787.
6. Raeder H, Johansson S, Holm PI et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet 2006: 38: 54-62.
7. Sagen JV, Bostad L, Njølstad PR, Søvik O. Enlarged nephrons and severe nondiabetic nephropathy in hepatocyte nuclear factor-1beta (HNF-1beta) mutation carriers. Kidney Int 2003: 64: 793-800.
8. Linder TH, Njølstad PR, Horikawa Y, Bostad L, Bell GI, Søvik O. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1β. Hum Mol Genet 1999: 8: 2001-2008.
9. Søvik O, Sagen J, Njølstad PR, Nyland H, Myhr KM. Contributions to the MODY5 phenotype. J Inher Metab Dis 2002: 25: 597-598.
10. Sagen JV, Raeder H, Hathout E et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 2004: 53: 2713-2718.
11. Pearson ER, Flechtner I, Njølstad PR et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006: 355: 467-477.
12. Pearson ER, Starkey BJ, Powell RJ et al. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003: 362: 1275-1281.
13. Pearson ER, Badman MK, Lockwood CR et al. Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1 alpha and -1 beta mutations. Diabetes Care 2004: 27: 1102-1107.
14. Vesterhus M, Raeder H, Johansson S, Molven A, Njølstad PR. Pancreatic exocrine dysfunction in maturity-onset diabetes of the young Type 3. Diabetes Care 2008: 31: 306-310.
15. Vesterhus M, Haldorsen IS, Raeder H, Molven A, Njølstad PR. Reduced pancreatic volume in hepatocyte nuclear factor 1A-maturity-onset diabetes of the young. J Clin Endocrinol Metab 2008: 93: 3505-3509.
16. Beckers D, Bellanne-Chantelot C, Maes M. Neonatal choletatic jaundice as the first symptom of a mutation in the hepatocyte nuclear factor-1β gene. J Pediatr 2007: 150: 313-314.
17. Raile K, Klopocki E, Holder M et al. Expanded clinical spectrum in hepatocyte nuclear factor-1β-maturity-onset diabetes of the young. J Clin Endocrinol Metab 2009: 94: 2658-2664.
18. Edghill EL, Bingham C, Ellard S, Hattersley AT. Mutations in hepatocyte nuclear factor-1beta and their related phenotypes. J Med Genet 2006: 43: 84-90.
19. Mayer C, Böttcher Y, Kovacs P, Halbritter J, Stumvoll M. Phenotype of a patient with a de novo mutation in the hepatocyte nuclear factor 1beta/maturity-onset diabetes of the young type 5 gene. Metabolism 2008: 57: 416-420.
20. Edghill EL, Bingham C, Slingerland S et al. Hepatocyte nuclear factor-1 beta muataions cause neonatal diabetes and trauterine growth retardation: support for a critical role of HNF-1 beta in human pancratetic development. Diabetes Med 2006: 23: 1301-1306.
21. Yorifuji T, Kurokawa K, Mamada M et al. Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1 beta gene due to germline mosaicism. J Clin Endocrinol Metabol 2004: 89: 2905-2908.
22. Chen Y, Gao Q, Zhao X et al. Systematic review of TCF2 anomalies in renal cysts and diabetes syndrome/maturity-onset diabetes of the young. Chin Med J 2010: 123: 3326-3333.